PILOT CLINICAL STUDY OF GCSF IN COMBINATION WITH DESIPRAMINE FOR AUTOLOGOUS STEM CELL MOBILIZATION IN MULTIPLE MYELOMA
Latest Information Update: 30 Mar 2023
At a glance
- Drugs Desipramine (Primary) ; Filgrastim (Primary) ; Filgrastim (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 02 Mar 2023 Status changed from completed to discontinued.
- 10 Dec 2019 Status changed from active, no longer recruiting to completed.
- 11 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 March 2015 as reported by ClinicalTrials.gov record.